Pharmaceuticals

VILANTEROL TREFENATATE

Human API suitable for respiratory diseases.

VORTIOXETINE

Human API for use in the treatment of central nervous system diseases. 

Human API suitable for pharmaceutical applications. It is a xanthine alkaloid compound, a central nervous stimulant that treats drowsiness, neurasthenia & coma and restores energy. Benefits:It conforms to EP 10.1 requirement

OXYTETRACYCLINE DIHYDRATE EP INJECTABLE

Oxytetracycline dihydrate designed for pharmaceutical applications. It is suitable for injectable forms.Benefits: Meets with EP and USP specificationsFDA certified

OXYTETRACYCLINE HYDROCHLORIDE EP INJECTABLE

Oxytetracycline hydrochloride designed for pharmaceutical applications. It is suitable for injections. Shelf life: 3 years.Benefits: Meets with EP 10 specificationsCEP available

OXYTETRACYCLINE HYDROCHLORIDE EP ORAL (D)

Oxytetracycline hydrochloride developed for pharmaceutical applications. It is suitable for oral dosage forms.Benefits: Meets with EP and USP specificationsCEP available

EUDRAGIT® L 100

Polymer developed for pharmaceutical preparations. It is applicable in all oral solid dosage forms including multi-particulates, regular and matrix tablets, hard as well as soft-gel capsules. It is suitable for drug delivery in small intestine jejunum. Benefits:Highly stable with enhanced bioavailabilityImproves drug effectivenessHelps to protect gastric mucosa from aggressive APIs

EUDRAGIT® NE 30 D

Polymer developed for oral solid dosage forms. It is suitable for sustained-release formulations. It is used in diffusion controlled coated multi-particulates and matrix tablets. It is also applicable in time-controlled formulations such as once-per-day dosing and pulsatile release. Benefits:Highly flexible, shows low permeability Offers pH-independent swellingNo plasticizer requiredImproves drug product effectivenessAvailable as 30% aqueous dispersion